News & Views
IDS Gains FDA Clearance for a New Specialist Assay
Apr 19 2012
Immunodiagnostic Systems Holdings plc, a leading producer of diagnostic testing kits and automated systems for the clinical and research markets, has received clearance from the US Food and Drugs Administration (FDA) for its Intact PTH automated immunoassay kit. The Intact PTH assay is intended for the quantitative determination of parathyroid hormone levels in human serum or plasma on the IDS-iSYS automated analyser. Results of the tests are to be used in the differential diagnosis of hypercalcemia and hypocalcemia resulting from disorders of calcium metabolism, which will enable doctors to more accurately diagnose parathyroid disease and to monitor patients undergoing renal dialysis and other diseases caused by calcium homeostasis. Ian Cookson, CEO of IDS, said: “As part of our strategy to diversify our product offering, we are pleased to have received FDA clearance for this important assay. The ability to offer Intact PTH on the IDS-iSYS in the US complements our automated 25 Hydroxy Vitamin D assay
and will further facilitate the placement of IDS- iSYS systems.”
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK
May 21 2024 Lagos, Nigeria